ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Budesonide Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-18T594
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Budesonide Market Insights and Forecast to 2028
BUY CHAPTERS

Global Budesonide Market Research Report 2026

Code: QYRE-Auto-18T594
Report
2026-01-26
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Cosmo Pharmaceuticals
TEVA
Mylan NV
Sandoz Inc
Chiesi Farmaceutici
Orion Corporation
Cipla Ltd
Salix
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod

Budesonide Market Size

The global Budesonide market was valued at US$ 8984 million in 2025 and is anticipated to reach US$ 11170 million by 2032, at a CAGR of 3.2% from 2026 to 2032.

Budesonide Market

Budesonide Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Budesonide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
This report delivers a comprehensive overview of the global Budesonide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Budesonide. The Budesonide market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Budesonide market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Budesonide manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Budesonide Market Report

Report Metric Details
Report Name Budesonide Market
Accounted market size in 2025 US$ 8984 million
Forecasted market size in 2032 US$ 11170 million
CAGR 3.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Injectable Suspension
  • Aerosols
  • Inhalation Powder
  • Tablet and Capsule
by Application
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Inflammatory Bowel Disease Treatment
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Budesonide manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Budesonide sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Budesonide Market growing?

Ans: The Budesonide Market witnessing a CAGR of 3.2% during the forecast period 2026-2032.

What is the Budesonide Market size in 2032?

Ans: The Budesonide Market size in 2032 will be US$ 11170 million.

What is the Budesonide Market share by region?

Ans: North America is the largest market with about 36% revenue market share.

What is the AstraZeneca share in Budesonide Market?

Ans: AstraZeneca is the largest manufacturer with about 56% revenue market share.

Who are the main players in the Budesonide Market report?

Ans: The main players in the Budesonide Market are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod

What are the Application segmentation covered in the Budesonide Market report?

Ans: The Applications covered in the Budesonide Market report are Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Others

What are the Type segmentation covered in the Budesonide Market report?

Ans: The Types covered in the Budesonide Market report are Injectable Suspension, Aerosols, Inhalation Powder, Tablet and Capsule

1 Budesonide Market Overview
1.1 Product Definition
1.2 Budesonide by Type
1.2.1 Global Budesonide Market Value by Type: 2025 vs 2032
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide by Application
1.3.1 Global Budesonide Market Value by Application: 2025 vs 2032
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Global Budesonide Market Size Estimates and Forecasts
1.4.1 Global Budesonide Revenue 2021–2032
1.4.2 Global Budesonide Sales 2021–2032
1.4.3 Global Budesonide Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Budesonide Market Competition by Manufacturers
2.1 Global Budesonide Sales Market Share by Manufacturers (2021–2026)
2.2 Global Budesonide Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Budesonide Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Budesonide, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Budesonide, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Budesonide, Product Types and Applications
2.7 Global Key Manufacturers of Budesonide, Date of Entry into the Industry
2.8 Global Budesonide Market Competitive Situation and Trends
2.8.1 Global Budesonide Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Budesonide Players Market Share by Revenue
2.8.3 Global Budesonide Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Budesonide Market Scenario by Region
3.1 Global Budesonide Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Budesonide Sales by Region: 2021–2032
3.2.1 Global Budesonide Sales by Region: 2021–2026
3.2.2 Global Budesonide Sales by Region: 2027–2032
3.3 Global Budesonide Revenue by Region: 2021–2032
3.3.1 Global Budesonide Revenue by Region: 2021–2026
3.3.2 Global Budesonide Revenue by Region: 2027–2032
3.4 North America Budesonide Market Facts & Figures by Country
3.4.1 North America Budesonide Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Budesonide Sales by Country (2021–2032)
3.4.3 North America Budesonide Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Market Facts & Figures by Country
3.5.1 Europe Budesonide Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Budesonide Sales by Country (2021–2032)
3.5.3 Europe Budesonide Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Market Facts & Figures by Region
3.6.1 Asia Pacific Budesonide Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Budesonide Sales by Region (2021–2032)
3.6.3 Asia Pacific Budesonide Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Budesonide Market Facts & Figures by Country
3.7.1 Latin America Budesonide Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Budesonide Sales by Country (2021–2032)
3.7.3 Latin America Budesonide Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Budesonide Sales by Country (2021–2032)
3.8.3 Middle East and Africa Budesonide Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Budesonide Sales by Type (2021–2032)
4.1.1 Global Budesonide Sales by Type (2021–2026)
4.1.2 Global Budesonide Sales by Type (2027–2032)
4.1.3 Global Budesonide Sales Market Share by Type (2021–2032)
4.2 Global Budesonide Revenue by Type (2021–2032)
4.2.1 Global Budesonide Revenue by Type (2021–2026)
4.2.2 Global Budesonide Revenue by Type (2027–2032)
4.2.3 Global Budesonide Revenue Market Share by Type (2021–2032)
4.3 Global Budesonide Price by Type (2021–2032)
5 Segment by Application
5.1 Global Budesonide Sales by Application (2021–2032)
5.1.1 Global Budesonide Sales by Application (2021–2026)
5.1.2 Global Budesonide Sales by Application (2027–2032)
5.1.3 Global Budesonide Sales Market Share by Application (2021–2032)
5.2 Global Budesonide Revenue by Application (2021–2032)
5.2.1 Global Budesonide Revenue by Application (2021–2026)
5.2.2 Global Budesonide Revenue by Application (2027–2032)
5.2.3 Global Budesonide Revenue Market Share by Application (2021–2032)
5.3 Global Budesonide Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sandoz Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Company Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Company Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Salix Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.7.1 Chiesi Farmaceutici Company Information
6.7.2 Chiesi Farmaceutici Description and Business Overview
6.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chiesi Farmaceutici Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Company Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Orion Corporation Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cipla Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Company Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Synmosa Biopharma Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Company Information
6.11.2 Lunan Better Pharma Description and Business Overview
6.11.3 Lunan Better Pharma Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Lunan Better Pharma Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Company Information
6.12.2 Shanghai Sine Promod Description and Business Overview
6.12.3 Shanghai Sine Promod Budesonide Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shanghai Sine Promod Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Industry Chain Analysis
7.2 Budesonide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Production Mode & Process Analysis
7.4 Budesonide Sales and Marketing
7.4.1 Budesonide Sales Channels
7.4.2 Budesonide Distributors
7.5 Budesonide Customer Analysis
8 Budesonide Market Dynamics
8.1 Budesonide Industry Trends
8.2 Budesonide Market Drivers
8.3 Budesonide Market Challenges
8.4 Budesonide Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Cosmo Pharmaceuticals
TEVA
Mylan NV
Sandoz Inc
Chiesi Farmaceutici
Orion Corporation
Cipla Ltd
Salix
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
List of Tables
 Table 1. Global Budesonide Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Budesonide Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Budesonide Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Budesonide Sales (M Units) of Key Manufacturers (2021–2026)
 Table 5. Global Budesonide Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Budesonide Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Budesonide Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Budesonide Average Price (USD/K Units) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Budesonide, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Budesonide, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Budesonide, Product Types and Applications
 Table 12. Global Key Manufacturers of Budesonide, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Budesonide Companies by Tier (Tier 1, Tier 2, Tier 3), based on Budesonide Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Budesonide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Budesonide Sales by Region (M Units), 2021–2026
 Table 18. Global Budesonide Sales Market Share by Region (2021–2026)
 Table 19. Global Budesonide Sales by Region (M Units), 2027–2032
 Table 20. Global Budesonide Sales Market Share by Region (2027–2032)
 Table 21. Global Budesonide Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Budesonide Revenue Market Share by Region (2021–2026)
 Table 23. Global Budesonide Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Budesonide Revenue Market Share by Region (2027–2032)
 Table 25. North America Budesonide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Budesonide Sales by Country (M Units), 2021–2026
 Table 27. North America Budesonide Sales by Country (M Units), 2027–2032
 Table 28. North America Budesonide Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Budesonide Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Budesonide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Budesonide Sales by Country (M Units), 2021–2026
 Table 32. Europe Budesonide Sales by Country (M Units), 2027–2032
 Table 33. Europe Budesonide Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Budesonide Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Budesonide Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Budesonide Sales by Region (M Units), 2021–2026
 Table 37. Asia Pacific Budesonide Sales by Region (M Units), 2027–2032
 Table 38. Asia Pacific Budesonide Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Budesonide Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Budesonide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Budesonide Sales by Country (M Units), 2021–2026
 Table 42. Latin America Budesonide Sales by Country (M Units), 2027–2032
 Table 43. Latin America Budesonide Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Budesonide Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Budesonide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Budesonide Sales by Country (M Units), 2021–2026
 Table 47. Middle East and Africa Budesonide Sales by Country (M Units), 2027–2032
 Table 48. Middle East and Africa Budesonide Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Budesonide Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Budesonide Sales (M Units) by Type (2021–2026)
 Table 51. Global Budesonide Sales (M Units) by Type (2027–2032)
 Table 52. Global Budesonide Sales Market Share by Type (2021–2026)
 Table 53. Global Budesonide Sales Market Share by Type (2027–2032)
 Table 54. Global Budesonide Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Budesonide Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Budesonide Revenue Market Share by Type (2021–2026)
 Table 57. Global Budesonide Revenue Market Share by Type (2027–2032)
 Table 58. Global Budesonide Price (USD/K Units) by Type (2021–2026)
 Table 59. Global Budesonide Price (USD/K Units) by Type (2027–2032)
 Table 60. Global Budesonide Sales (M Units) by Application (2021–2026)
 Table 61. Global Budesonide Sales (M Units) by Application (2027–2032)
 Table 62. Global Budesonide Sales Market Share by Application (2021–2026)
 Table 63. Global Budesonide Sales Market Share by Application (2027–2032)
 Table 64. Global Budesonide Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Budesonide Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Budesonide Revenue Market Share by Application (2021–2026)
 Table 67. Global Budesonide Revenue Market Share by Application (2027–2032)
 Table 68. Global Budesonide Price (USD/K Units) by Application (2021–2026)
 Table 69. Global Budesonide Price (USD/K Units) by Application (2027–2032)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 73. AstraZeneca Budesonide Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 78. Teva Budesonide Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 83. Mylan Budesonide Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 88. Sandoz Budesonide Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Cosmo Pharmaceuticals Company Information
 Table 91. Cosmo Pharmaceuticals Description and Business Overview
 Table 92. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 93. Cosmo Pharmaceuticals Budesonide Product
 Table 94. Cosmo Pharmaceuticals Recent Developments/Updates
 Table 95. Salix Company Information
 Table 96. Salix Description and Business Overview
 Table 97. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 98. Salix Budesonide Product
 Table 99. Salix Recent Developments/Updates
 Table 100. Chiesi Farmaceutici Company Information
 Table 101. Chiesi Farmaceutici Description and Business Overview
 Table 102. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 103. Chiesi Farmaceutici Budesonide Product
 Table 104. Chiesi Farmaceutici Recent Developments/Updates
 Table 105. Orion Corporation Company Information
 Table 106. Orion Corporation Description and Business Overview
 Table 107. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 108. Orion Corporation Budesonide Product
 Table 109. Orion Corporation Recent Developments/Updates
 Table 110. Cipla Company Information
 Table 111. Cipla Description and Business Overview
 Table 112. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 113. Cipla Budesonide Product
 Table 114. Cipla Recent Developments/Updates
 Table 115. Synmosa Biopharma Company Information
 Table 116. Synmosa Biopharma Description and Business Overview
 Table 117. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 118. Synmosa Biopharma Budesonide Product
 Table 119. Synmosa Biopharma Recent Developments/Updates
 Table 120. Lunan Better Pharma Company Information
 Table 121. Lunan Better Pharma Description and Business Overview
 Table 122. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 123. Lunan Better Pharma Budesonide Product
 Table 124. Lunan Better Pharma Recent Developments/Updates
 Table 125. Shanghai Sine Promod Company Information
 Table 126. Shanghai Sine Promod Description and Business Overview
 Table 127. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 128. Shanghai Sine Promod Budesonide Product
 Table 129. Shanghai Sine Promod Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Budesonide Distributors List
 Table 133. Budesonide Customers List
 Table 134. Budesonide Market Trends
 Table 135. Budesonide Market Drivers
 Table 136. Budesonide Market Challenges
 Table 137. Budesonide Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Budesonide
 Figure 2. Global Budesonide Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Budesonide Market Share by Type: 2025 & 2032
 Figure 4. Injectable Suspension Product Picture
 Figure 5. Aerosols Product Picture
 Figure 6. Inhalation Powder Product Picture
 Figure 7. Tablet and Capsule Product Picture
 Figure 8. Global Budesonide Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Budesonide Market Share by Application: 2025 & 2032
 Figure 10. Respiratory Disease Treatment
 Figure 11. Nose Disease Treatment
 Figure 12. Inflammatory Bowel Disease Treatment
 Figure 13. Others
 Figure 14. Global Budesonide Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Budesonide Market Size (US$ Million), 2021–2032
 Figure 16. Global Budesonide Sales (M Units), 2021–2032
 Figure 17. Global Budesonide Average Price (USD/K Units), 2021–2032
 Figure 18. Budesonide Report Years Considered
 Figure 19. Budesonide Sales Share by Manufacturers in 2025
 Figure 20. Global Budesonide Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Budesonide Players: Market Share by Revenue in Budesonide in 2025
 Figure 22. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Budesonide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Budesonide Sales Market Share by Country (2021–2032)
 Figure 25. North America Budesonide Revenue Market Share by Country (2021–2032)
 Figure 26. U.S. Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Budesonide Sales Market Share by Country (2021–2032)
 Figure 29. Europe Budesonide Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Budesonide Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Budesonide Revenue Market Share by Region (2021–2032)
 Figure 37. China Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Taiwan Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Indonesia Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Thailand Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Malaysia Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Philippines Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Budesonide Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Budesonide Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Budesonide Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Budesonide Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. U.A.E Budesonide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Budesonide by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Budesonide by Type (2021–2032)
 Figure 59. Global Budesonide Price (USD/K Units) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Budesonide by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Budesonide by Application (2021–2032)
 Figure 62. Global Budesonide Price (USD/K Units) by Application (2021–2032)
 Figure 63. Budesonide Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Budesonide Inhaler Market Research Report 2024
Global Budesonide and Formoterol Powder Inhalation Market Research Report 2024
Global Budesonide and Formoterol Inhalation Market Research Report 2024
Global Corticosteroids Inhalation Formulation Market Research Report 2024
Global Budesonide Commercial Medicine Market Research Report 2025
Budesonide Aerosol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COPD Inhaler Market Research Report 2025
Global Inhalers and Nebulizers Market Research Report 2025
Global Fluticasone Propionate Inhalers Market Research Report 2024
Budesonide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmicort Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inhalation Powder Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Budesonide Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tablet and Capsule Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Suspension Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aerosols Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Budesonide Nasal Spray Market Research Report 2024
Global Medical Nebulizer Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions